Clinical trialNCT07197554RecruitingPhase 1Interventional

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

SponsorSEED Therapeutics, Inc.Enrollment171Advanced Solid TumorsBiliary Tract Cancer (BTC)Ewing SarcomaHepatocellular Carcinoma (HCC)

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A Phase 1/1B Study of ST-01156 in Patients with Advanced Solid Malignancies

clinicaltrials.gov ↗

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

the City of Hope National Medical Center
Duarte, California, United States
Daneng Li
Recruiting
Hoag Memorial Hospital
Newport Beach, California, United States
Alain Mita
Recruiting
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Suzanne George, MD
Recruiting
Mass General Brigham Cancer Institute
Boston, Massachusetts, United States
Gregory Cote
Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Robert Maki
Recruiting
the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Jordi Rodon Ahnert
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

ST-01156

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Dec 2025
Primary completion: 31 Dec 2029
Completion: 31 Dec 2029
Last update posted: 2 Jun 2026
Registered enrollment: 171
Registry id: NCT07197554

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.